Jump to content

Artificial Cells, Nanomedicine, and Biotechnology

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jonesey95 (talk | contribs) at 14:02, 7 September 2016 (Fix unsupported parameters in infobox). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Artificial Cells, Blood Substitutes, and Biotechnology
DisciplineBiochemistry/Biotechnology
LanguageEnglish
Edited byThomas M.S. Change, O.C. M.D., C.M., Ph.D., FRCP(C), FRS(C)
Publication details
History1973–present
Publisher
Informa Healthcare (UK)
Frequency8 issues per year
no
Standard abbreviations
ISO 4ABB
Indexing
ISSN1532-4184 (print)
1073-1199 (web)
Links

Artificial Cells, Blood Substitutes, and Biotechnology is an academic journal that publishes review articles on the development of artificial cells, tissue engineering, artificial organs, blood substittues, cell therapy, gene and drug delivery systems, bioencapsulation nanosensors, nanodevices and other areas of biotechnology. It is published by Informa Healthcare.

Core Areas

  • Tissues and organs
  • Artificial cells
  • Molecules
  • Blood substitutes
  • Tissue engineering
  • Stem cells
  • Gene therapy
  • Drug delivery

Editor-in-Chief

Thomas M.S. Chang, O.C., M.D., C.M., Ph.D., FRCP(C), FRS(C) is the Editor-in-Chief of Artificial Cells,

Blood Substitutes, and Biotechnology.[1]

Publication Format

Artificial Cells, Blood Substitutes, and Biotechnology publishes 8 issues per year in simultaneous print and online editions.

References

  1. ^ "Editorial Board Members". informhealthcare.com. Retrieved 2009-09-16.